🔎 Trials Near Me

Akèy › Neuroblastom › Maryland

Etid klinik pou Neuroblastom nan Maryland

8 etid pou Neuroblastom ap chèche patisipan nan sit nan Maryland.

Vil nan Maryland

Tèks ofisyèl etid la (Anglè)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • ak 1 plis
Ap rekriteFaz 3
Jiska laj 30 · Tout sèks · Mizajou Oct 2, 2026 · NCT06172296

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
4 Weeks · Tout sèks · Mizajou Oct 2, 2026 · NCT01109394

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 3 a 35 · Tout sèks · Mizajou Sep 24, 2026 · NCT06995872

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 4 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT01005654

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • University of Maryland/Greenebaum Cancer Center, Baltimore
  • Sinai Hospital of Baltimore, Baltimore
  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Ap rekriteFaz 3
365 Days – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03126916

SPEARHEAD-3 Pediatric Study

  • National Institutes of Health, Bethesda
Ap rekriteFaz 1/2
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors

  • National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 120 · Tout sèks · Mizajou Jun 15, 2026 · NCT06041516

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Ap rekriteFaz 2
Laj 1 a 50 · Tout sèks · Mizajou Mar 13, 2026 · NCT01804634

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.